R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10 by Alex Simpson, Sreeram V Ramagopalan

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 12 by Ben Bray, Sreeram V Ramagopalan

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 11 by Ben Bray, Sreeram V Ramagopalan

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 17 by Paul Arora, Sreeram V Ramagopalan

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 13 by Benjamin D Bray, Sreeram V Ramagopalan

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 14 by Benjamin D Bray, Sreeram V Ramagopalan

Can real-world data really replace randomised clinical trials? by Sreeram V. Ramagopalan, Alex Simpson, Cormac Sammon

Get full text

A review of 25 years of National Institute of Health and Care Excellence decision making by Xin Zhang, Natalie Tikhonovsky, Sreeram V Ramagopalan

Access in all areas? A round up of developments in market access and health technology assessment: part 3 by Alice Beattie, Catrin Treharne, Sreeram V Ramagopalan

RWE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 16 by Alejandra Castanon, Antonia Tsvetanova, Sreeram V Ramagopalan

Access in all areas? a round up of developments in market access and health technology assessment: part 4 by Alice Beattie, Catrin Treharne, Sreeram V Ramagopalan

Decrease in rate of multiple sclerosis-related hospitalizations in Portugal [version 1; referees: 2 approved] by Marta Pereira, Dimitra Lambrelli, Sreeram V. Ramagopalan

Get full text

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 15 by Alejandra Castanon, Benjamin D Bray, Sreeram V Ramagopalan

Sleep and BMI: Do (Fitbit) bands aid? [version 2; referees: 2 approved] by Laura McDonald, Faisal Mehmud, Sreeram V. Ramagopalan

Get full text

Access in all areas? A round up of developments in market access and health technology assessment: part 1 by Ramiro Gilardino, Catrin Treharne, Silvy Mardiguian, Sreeram V Ramagopalan

Access in all areas? A round up of developments in market access and HTA: part 5 by Alice Beattie, Francisco Olivenca, Catrin Treharne, Sreeram V Ramagopalan

Access in all areas? A round up of developments in market access and health technology assessment: part 2 by Alice Beattie, Catrin Treharne, Silvy Mardiguian, Sreeram V Ramagopalan

Access in all areas? A roundup of developments in market access and health technology assessment: part 6 by Annie Jullien Pannelay, Ramiro E Gilardino, Sreeram V Ramagopalan

First in class, best in class or a wild card: who will dominate the anti-obesity medication market? by Emma Collins, Alice Beattie, Sreeram V Ramagopalan, Jonathan Pearson-Stuttard

EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out? by Alejandra Castanon, Rebecca Sloan, Luisamanda Selle Arocha, Sreeram V Ramagopalan